Lysocardiolipin Acyltransferase 1-Anaplastic Lymphoma Receptor Tyrosine Kinase: A Novel Crizotinib-Sensitive Fusion Gene in Lung Adenocarcinoma

被引：1
|
作者：
Bu, Kunpeng [1 ]
Lu, Yang [1 ]
Liu, Xiaoyan [2 ]
Cheng, Chunyan [2 ]
Li, Bixun [1 ]
机构：
[1] Guangxi Med Univ, Dept Comprehens Internal Med, Affiliated Tumor Hosp, Nanning 530021, Guangxi, Peoples R China
[2] OrigiMed, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 04期
关键词：
ALCAT1;
D O I：
10.1016/j.jtho.2019.11.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E55 / E57
页数：4
相关论文
共 50 条
  • [1] Identification of a novel crizotinib-sensitive MET-ATXN7L1 gene fusion variant in lung adenocarcinoma by next generation sequencing
    Zhu, Y. C.
    Wang, W. X.
    Xu, C. W.
    Zhang, Q. X.
    Du, K. Q.
    Chen, G.
    Lv, T. F.
    Song, Y.
    ANNALS OF ONCOLOGY, 2018, 29 (12) : 2392 - 2393
  • [2] Case report: targeted therapy of malignant pleural mesothelioma with anaplastic lymphoma kinase receptor tyrosine kinase gene fusion mutation by crizotinib
    Wu, Yufeng
    Zhao, Yuhua
    Yu, Limeng
    Wang, Ruilin
    Feng, Wen
    Wu, Yingxi
    Wang, Lili
    Chen, Haiyang
    He, Zhen
    Wang, Qiming
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (11)
  • [3] Melanoregulin-Anaplastic Lymphoma Kinase (ALK), a Novel ALK Rearrangement That Responds to Crizotinib in Lung Adenocarcinoma
    Wang, Leiming
    Yao, Shuyang
    Teng, Lianghong
    Zhang, Weiwei
    Chen, Li
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : E44 - E46
  • [4] Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient
    Tian, Qing
    Deng, Wen-Jing
    Li, Zong-Wei
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (04)
  • [5] Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib
    Liu, Yutao
    Liu, Tianfeng
    Li, Nan
    Wang, Tao
    Pu, Yue
    Lin, Rui
    LUNG CANCER, 2019, 129 : 92 - 94
  • [6] Cytomorphological features of lung adenocarcinoma with anaplastic lymphoma kinase gene rearrangement
    Shukla, Saumya
    Husain, Nuzhat
    Gupta, Anurag
    Anand, Nidhi
    JOURNAL OF CYTOLOGY, 2019, 36 (01) : 8 - 12
  • [7] Concomitant expression of exon 19 mutation epidermal growth factor receptor and anaplastic lymphoma kinase gene rearrangement in metastatic adenocarcinoma lung responsive to crizotinib
    Purkayastha, Abhishek
    Kapoor, Amul
    Singh, Harinder Pal
    Sarin, Arti
    Sengupta, Prasanta
    Singh, Sankalp
    Bisht, Niharika
    Husain, Azhar
    LUNG INDIA, 2018, 35 (06) : 527 - 529
  • [8] Identification of a novel NPM1-ROS1 fusion in a lung adenocarcinoma and sensitive to crizotinib treatment
    Ma, Hongxia
    Zhang, Qian
    Duan, Qianqian
    Zhang, Qin
    Li, Fengsen
    LUNG CANCER, 2021, 152 : 196 - 198
  • [9] Comparison of salvage surgeries for lung adenocarcinoma treated with anaplastic lymphoma kinase-tyrosine kinase inhibitors
    Iwamoto, Naoya
    Matsuura, Yosuke
    Ninomiya, Hironori
    Uchibori, Ken
    Yanagitani, Noriko
    Hashimoto, Kohei
    Ichinose, Junji
    Nakao, Masayuki
    Okumura, Sakae
    Nishio, Makoto
    Mun, Mingyon
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 4
  • [10] Molecular characterization of WDCP, a novel fusion partner for the anaplastic lymphoma tyrosine kinase ALK
    Yokoyama, Noriko
    Miller, W. Todd
    BIOMEDICAL REPORTS, 2015, 3 (01) : 9 - 13
12345